Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The fructose-specific phosphotransferase system of Streptococcus mutans is a multi-protein, energy-coupling membrane complex responsible for the import and concomitant phosphorylation of fructose. This system utilizes phosphoenolpyruvate (PEP) to drive the transfer of phosphate groups first through the cytoplasmic proteins EI and HPr and then through membrane-bound, fructose-specific Enzyme II subunits. The PTS mediates both transport and initial metabolism of fructose by converting it to fructose-1-phosphate or fructose-6-phosphate, which feeds into central metabolic pathways. The fructose PTS plays major roles in carbohydrate acquisition, biofilm maturation, acid production, and stress responses, and is crucial for the pathogenicity of S. mutans in dental caries development. It is not a direct therapeutic target currently, but manipulation of its activity (for example, through dietary interventions like xylitol or potential inhibitors) can affect bacterial virulence and cariogenic potential. Note: The system described is an enzymatic transporter complex integral to S. mutans’ metabolism and virulence, not a receptor or single-enzyme drug target. All details supplied reflect what is available in the literature; further structural or mechanistic data may require referencing primary microbial biochemistry resources.
Transport and phosphorylation of fructose via a multicomponent phosphorylation cascade (phosphoenolpyruvate-dependent group translocation) leading to fructose-1-phosphate or fructose-6-phosphate formation. Indirect mechanisms include alteration of biofilm structure and metabolic stress upon sugar analogs (e.g., xylitol, 2-deoxyglucose).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fructose-specific phosphotransferase system of Streptococcus mutans (PTS^Fru^ (commonly, "fructose PTS" or "Fru-PTS" in the literature; formal consistent abbreviation not widely standardized)).